The Active Pharmaceutical Ingredient (API) market has seen growth due to increased abbreviated new drug applications and the involvement of Indian companies in drug master files, although it faces challenges from stringent EU regulations. The market is segmented by synthesis, manufacturer type, product, therapy, and geography, with key areas including synthetic and biotech APIs. The report analyzes current and future trends, challenges, and opportunities, providing insights into market segments and technological developments.

1. v
Active Pharmaceutical Ingredient (API) Market
Size, Share, Global Trends, Company Profile, Demand, Insights,
Analysis, Research, Report, Opportunities, Forecast, 2014 - 2022
www.alliedmarketresearch.com
Upcoming: 2017
Category: Pharmaceuticals

2. Active Pharmaceutical Ingredient (API) Market Overview
• Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered
the demand for API market.
• Furthermore, Indian companies making increased entries related to Drug Master File
(DMF) indicates APIs market gaining traction.
• Stringent regulatory policies in the European Union is likely to restrain market
growth. Patent expiry of biological drugs creates new growth opportunities for key API
manufacturers.
• The report segments the market on the basis of synthesis, type of manufacturer, type
and therapy.
• Based on synthesis, this market is segmented into synthetic API and biotech API.
• The former is further segmented into Innovative synthetic APIS and generic synthetic
APIS, while the latter is further segmented on the basis of products and type.

3. Active Pharmaceutical Ingredient (API) Market Overview
• The biotech APIS market, by product is further segmented into monoclonal antibodies,
recombinant proteins and vaccines.
• On the basis of type of manufacturer, this market is segmented into captive API
manufacturers, merchant API manufacturers, innovative APIS and generic APIS.
• On the basis of type, the market is segmented into innovative APIS segment and
generic APIS segment.
• On the basis of therapy, the market is segmented into oncology, diabetes,
cardiovascular disease, Cns and neurological disorders, orthopedic disorders,
nephrology, ophthalmology, pulmonology, gastrointestinal disorders and endocrinology.
• On the basis of geography, the market is segmented into North America, Europe, Asia-
Pacific, and Latin America, Middle East & Africa (LAMEA).

4. Key Benefits of Active Pharmaceutical Ingredient (API) Market
• The report provides a comprehensive analysis of current & future market trends, key
market challenges and emerging avenues for the growth of this market globally.
• The report offers latest technological innovations and the recent R&D developments.
• The report offers an insight into competitive landscape in terms of new technological
developments, untapped segments, and value chain analysis.
• This report entails the detailed quantitative analysis of the current market and
estimations through 2014 and 2020, which assists in identifying the prevailing market
opportunities.
• The report offers detailed segmentation and analyzes the key segments in terms of
market size by value and volume and country-level analysis to provide an in-depth
understanding of the market.

5. Active Pharmaceutical Ingredient (API) Market Segments
 By Synthesis
 Synthetic Active Pharmaceutical Ingredient
• Innovative Synthetic APIS
• Generic Synthetic APIS
 By Product
• Monoclonal Antibodies
• Recombinant Proteins
• Vaccines
 By Type of Manufacturer
 Captive API Manufacturers
 Merchant API Manufacturers
• Innovative APIS
• Generic APIS

6. Stay With US
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States.
E-mail :
help@alliedmarketresearch.com
Telephone
Direct : +1 (617) 674-4143
Toll Free : +1 (855) 711-1555
Fax : +1 (855) 550-5975
Thank You!
For More Details
https://www.alliedmarketresearch.com/active-pharmaceutical-ingredient-market